173 related articles for article (PubMed ID: 16303035)
21. Addition of a H2 receptor antagonist to PPI improves acid control and decreases nocturnal acid breakthrough.
Mainie I; Tutuian R; Castell DO
J Clin Gastroenterol; 2008 Jul; 42(6):676-9. PubMed ID: 18496394
[TBL] [Abstract][Full Text] [Related]
22. Persistent acid reflux and symptoms in patients with Barrett's oesophagus on proton-pump inhibitor therapy.
Basu KK; Bale R; West KP; de Caestecker JS
Eur J Gastroenterol Hepatol; 2002 Nov; 14(11):1187-92. PubMed ID: 12439112
[TBL] [Abstract][Full Text] [Related]
23. Efficacy in intra-oesophageal acid suppression may decrease after 2-year continuous treatment with proton pump inhibitors.
Frazzoni M; Manno M; De Micheli E; Savarino V
Dig Liver Dis; 2007 May; 39(5):415-21. PubMed ID: 17379591
[TBL] [Abstract][Full Text] [Related]
24. Esophageal acid exposure on proton pump inhibitors in unselected asymptomatic gastroesophageal reflux disease patients.
Grigolon A; Cantù P; Savojardo D; Conte D; Penagini R
J Clin Gastroenterol; 2008 Oct; 42(9):969-73. PubMed ID: 18719508
[TBL] [Abstract][Full Text] [Related]
25. Heartburn in primary care: problems below the surface.
Holtmann G; Maldonado-Lopez E; Haag S
J Gastroenterol; 2004 Nov; 39(11):1027-34. PubMed ID: 15580394
[TBL] [Abstract][Full Text] [Related]
26. Therapy with gastric acidity inhibitors increases the risk of acute gastroenteritis and community-acquired pneumonia in children.
Canani RB; Cirillo P; Roggero P; Romano C; Malamisura B; Terrin G; Passariello A; Manguso F; Morelli L; Guarino A;
Pediatrics; 2006 May; 117(5):e817-20. PubMed ID: 16651285
[TBL] [Abstract][Full Text] [Related]
27. Pharmacokinetics and pharmacodynamics of acid-suppressive agents in patients with gastroesophageal reflux disease.
Schentag JJ; Goss TF
Am J Hosp Pharm; 1993 Apr; 50(4 Suppl 1):S7-10. PubMed ID: 8097364
[TBL] [Abstract][Full Text] [Related]
28. Effect of proton pump inhibitors on markers of risk for high-grade dysplasia and oesophageal cancer in Barrett's oesophagus.
Hillman LC; Chiragakis L; Shadbolt B; Kaye GL; Clarke AC
Aliment Pharmacol Ther; 2008 Feb; 27(4):321-6. PubMed ID: 18047565
[TBL] [Abstract][Full Text] [Related]
29. Nocturnal acid breakthrough in children with reflux esophagitis taking proton pump inhibitors.
Pfefferkorn MD; Croffie JM; Gupta SK; Molleston JP; Eckert GJ; Corkins MR; Fitzgerald JF
J Pediatr Gastroenterol Nutr; 2006 Feb; 42(2):160-5. PubMed ID: 16456408
[TBL] [Abstract][Full Text] [Related]
30. Evolving issues in the management of reflux disease?
Yuan Y; Hunt RH
Curr Opin Gastroenterol; 2009 Jul; 25(4):342-51. PubMed ID: 19417644
[TBL] [Abstract][Full Text] [Related]
31. The extent of oesophageal acid exposure overlap among the different gastro-oesophageal reflux disease groups.
Shapiro M; Green C; Faybush EM; Esquivel RF; Fass R
Aliment Pharmacol Ther; 2006 Jan; 23(2):321-9. PubMed ID: 16393313
[TBL] [Abstract][Full Text] [Related]
32. Discontinuation of proton pump inhibitors in patients on long-term therapy: a double-blind, placebo-controlled trial.
Björnsson E; Abrahamsson H; Simrén M; Mattsson N; Jensen C; Agerforz P; Kilander A
Aliment Pharmacol Ther; 2006 Sep; 24(6):945-54. PubMed ID: 16948806
[TBL] [Abstract][Full Text] [Related]
33. Review of immediate-release omeprazole for the treatment of gastric acid-related disorders.
Castell D
Expert Opin Pharmacother; 2005 Nov; 6(14):2501-10. PubMed ID: 16259581
[TBL] [Abstract][Full Text] [Related]
34. Introduction. GERD warrants increased physician appreciation and improved treatment.
Webb DD
Postgrad Med; 2001 Oct; Spec No():5-10. PubMed ID: 11868429
[TBL] [Abstract][Full Text] [Related]
35. The pharmacological management of gastroesophageal reflux disease.
Lowe RC; Wolfe MM
Minerva Gastroenterol Dietol; 2004 Sep; 50(3):227-37. PubMed ID: 15729198
[TBL] [Abstract][Full Text] [Related]
36. The diagnosis of gastroesophageal reflux disease.
Dughera L; Navino M; Cassolino P; Pellicano R
Minerva Gastroenterol Dietol; 2007 Jun; 53(2):143-52. PubMed ID: 17557042
[TBL] [Abstract][Full Text] [Related]
37. Review article: alternative approaches to the long-term management of GERD.
Fennerty MB
Aliment Pharmacol Ther; 2005 Dec; 22 Suppl 3():39-44. PubMed ID: 16303036
[TBL] [Abstract][Full Text] [Related]
38. GERD and Barrett's esophagus: diagnostic and management strategies in the geriatric population.
Morganstern B; Anandasabapathy S
Geriatrics; 2009 Jul; 64(7):9-12. PubMed ID: 19586085
[TBL] [Abstract][Full Text] [Related]
39. Analysis of the acidity index and integrated intragastric acidity in 645 patients presenting with gastroesophageal reflux disease symptoms.
Blonski WC; Shih GL; Brensinger CM; Katzka DA; Metz DC
Scand J Gastroenterol; 2006 Apr; 41(4):382-9. PubMed ID: 16635904
[TBL] [Abstract][Full Text] [Related]
40. Long-term gastroesophageal reflux disease therapy improves reflux symptoms in elderly patients: five-year prospective study in community medicine.
Miyamoto M; Haruma K; Kuwabara M; Nagano M; Okamoto T; Tanaka M
J Gastroenterol Hepatol; 2007 May; 22(5):639-44. PubMed ID: 17444849
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]